Literature DB >> 3536204

The diabetic foot: pathophysiology and treatment.

M E Edmonds.   

Abstract

The diabetic foot can be classified into the neuropathic foot, characterized by the neuropathic ulcer, the Charcot joint and neuropathic oedema associated with a good circulation, in which neuropathy predominates, and the ischaemic foot in which atherosclerosis is the dominant factor leading to a reduction in blood flow with absent pulses. In the neuropathic foot, blood flow is increased, the vessels are still and dilated as a result of medial wall calcification and there is evidence for arteriovenous shunting. The neuropathic ulcer characteristically develops on the plantar surface following inflammatory autolysis and haematoma formation under neglected callosities. Chiropody is therefore the mainstay of treatment and recurrence is prevented by redistribution of weight bearing forces by moulded insoles in special footwear. Charcot osteoarthropathy is often preceded by fracture which is a further complication of diabetic neuropathy and which precipitates the rapid bone and joint destruction of the Charcot joint. Neuropathic oedema responds to ephedrine with a reduction in peripheral flow and an increase in urinary sodium excretion. The ischaemic foot is characterized by rest pain, ulceration and gangrene. Medical management can be successful in up to 72%, the remainder needing arteriography to assess suitability for arterial reconstruction or angioplasty. In the diabetic leg, atherosclerosis is predominant in the branches of the popliteal artery making arterial reconstruction difficult. Optimum care of the diabetic foot is provided in a diabetic foot clinic where the skills of chiropodist, shoe-fitter and nurse receive full support from physician and surgeon. Many lesions of the diabetic foot are avoidable and thus patient education is the cornerstone of prevention.

Entities:  

Mesh:

Year:  1986        PMID: 3536204     DOI: 10.1016/s0300-595x(86)80079-2

Source DB:  PubMed          Journal:  Clin Endocrinol Metab        ISSN: 0300-595X


  12 in total

Review 1.  Cost-effective management of diabetic foot ulcers. A review.

Authors:  G Ragnarson-Tennvall; J Apelqvist
Journal:  Pharmacoeconomics       Date:  1997-07       Impact factor: 4.981

2.  Treatment of diabetic polyneuropathy with the neurotrophic peptide ORG 2766.

Authors:  G D Valk; A C Kappelle; A M Tjon-A-Tsien; B Bravenboer; K Bakker; R P Michels; C M Groenhout; F W Bertelsmann
Journal:  J Neurol       Date:  1996-03       Impact factor: 4.849

3.  The diabetic foot: magnetic resonance imaging evaluation.

Authors:  J Beltran; D S Campanini; C Knight; M McCalla
Journal:  Skeletal Radiol       Date:  1990       Impact factor: 2.199

4.  Fracture of the os peroneum and rupture of the peroneus longus tendon as a complication of diabetic neuropathy.

Authors:  D T Truong; R G Dussault; P A Kaplan
Journal:  Skeletal Radiol       Date:  1995-11       Impact factor: 2.199

5.  Chronic Sciatic Neuropathy in Rat Reduces Voluntary Wheel-Running Activity With Concurrent Chronic Mechanical Allodynia.

Authors:  Ryan A Whitehead; Nicholas L Lam; Melody S Sun; Joshua Sanchez; Shahani Noor; Arden G Vanderwall; Timothy R Petersen; Hugh B Martin; Erin D Milligan
Journal:  Anesth Analg       Date:  2017-01       Impact factor: 5.108

6.  Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: a cohort study.

Authors:  M A Gershater; M Löndahl; P Nyberg; J Larsson; J Thörne; M Eneroth; J Apelqvist
Journal:  Diabetologia       Date:  2008-11-27       Impact factor: 10.122

Review 7.  The pro-inflammatory environment in recalcitrant diabetic foot wounds.

Authors:  Jorge Berlanga Acosta; Diana Garcia del Barco; Danay Cibrian Vera; William Savigne; Pedro Lopez-Saura; Gerardo Guillen Nieto; Gregory S Schultz
Journal:  Int Wound J       Date:  2008-10       Impact factor: 3.315

8.  Cardiovascular Autonomic Dysfunction Predicts Diabetic Foot Ulcers in Patients With Type 2 Diabetes Without Diabetic Polyneuropathy.

Authors:  Jae-Seung Yun; Seon-Ah Cha; Tae-Seok Lim; Eun-Young Lee; Ki-Ho Song; Yu-Bae Ahn; Ki-Dong Yoo; Joon-Sung Kim; Yong-Moon Park; Seung-Hyun Ko
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

9.  Tissue Oxygenation Measurements to Aid Scalpel Debridement Removal in Patients With Diabetes.

Authors:  Kacie Kaile; Jagadeesh Mahadevan; Kevin Leiva; Dinesh Khandavilli; Sivakumar Narayanan; Varalakshmi Muthukrishnan; Wensong Wu; Viswanathan Mohan; Anuradha Godavarty
Journal:  J Diabetes Sci Technol       Date:  2021-02-20

10.  TUG1 enhances high glucose-impaired endothelial progenitor cell function via miR-29c-3p/PDGF-BB/Wnt signaling.

Authors:  Yang Li; Kangkang Zhi; Shilong Han; Xue Li; Maoquan Li; Weishuai Lian; Haijun Zhang; Xiaoping Zhang
Journal:  Stem Cell Res Ther       Date:  2020-10-15       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.